Business Description
Sorrento Therapeutics Inc
NAICS : 325414
SIC : 8731
ISIN : US83587F2020
Description
Sorrento Therapeutics Inc is a clinical and commercial-stage biopharmaceutical company developing a portfolio of next-generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. Its multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies (G-MAB library), immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs), and oncolytic virus (Seprehvec). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including COVI-AMG, COVIDROPS, COVISHIELD, FUJOVEE (Abivertinib), and OQORY (Covi-MSC), and diagnostic test solutions, including COVITRACK and COVIMARK.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.3 | |||||
| 9-Day RSI | 34.65 | |||||
| 14-Day RSI | 40.49 | |||||
| 6-1 Month Momentum % | -65.71 | |||||
| 12-1 Month Momentum % | -92.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -378.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.23 | |||||
| EV-to-Forward-EBIT | -2.7 | |||||
| EV-to-EBITDA | -0.24 | |||||
| EV-to-Revenue | 1.99 | |||||
| EV-to-Forward-Revenue | 3.22 | |||||
| Earnings Yield (Greenblatt) % | -434.78 | |||||
| FCF Yield % | -24517.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SRNE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sorrento Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 64.27 | ||
| EPS (TTM) ($) | -1.12 | ||
| Beta | 1.37 | ||
| Volatility % | 245.34 | ||
| 14-Day RSI | 40.49 | ||
| 14-Day ATR ($) | 0.004284 | ||
| 20-Day SMA ($) | 0.003385 | ||
| 12-1 Month Momentum % | -92.17 | ||
| 52-Week Range ($) | 0.0001 - 0.2495 | ||
| Shares Outstanding (Mil) | 551.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sorrento Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sorrento Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sorrento Therapeutics Inc Frequently Asked Questions
What is Sorrento Therapeutics Inc(SRNE)'s stock price today?
The current price of SRNE is $0.00. The 52 week high of SRNE is $0.25 and 52 week low is $0.00.
When is next earnings date of Sorrento Therapeutics Inc(SRNE)?
The next earnings date of Sorrento Therapeutics Inc(SRNE) is 2024-11-29 Est..
Does Sorrento Therapeutics Inc(SRNE) pay dividends? If so, how much?
Sorrento Therapeutics Inc(SRNE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers